K ATP channels in cerebral hemodynamics: a systematic review of preclinical and clinical studies
Cumulative evidence suggests that ATP-sensitive potassium (K ) channels act as a key regulator of cerebral blood flow (CBF). This implication seems to be complicated, since K channels are expressed in several vascular-related structures such as smooth muscle cells, endothelial cells and pericytes. I...
Gespeichert in:
Veröffentlicht in: | Frontiers in neurology 2024, Vol.15, p.1417421 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Cumulative evidence suggests that ATP-sensitive potassium (K
) channels act as a key regulator of cerebral blood flow (CBF). This implication seems to be complicated, since K
channels are expressed in several vascular-related structures such as smooth muscle cells, endothelial cells and pericytes. In this systematic review, we searched PubMed and EMBASE for preclinical and clinical studies addressing the involvement of K
channels in CBF regulation. A total of 216 studies were screened by title and abstract. Of these, 45 preclinical and 6 clinical studies were included. Preclinical data showed that K
channel openers (KCOs) caused dilation of several cerebral arteries including pial arteries, the middle cerebral artery and basilar artery, and K
channel inhibitor (KCI) glibenclamide, reversed the dilation. Glibenclamide affected neither the baseline CBF nor the baseline vascular tone. Endothelium removal from cerebral arterioles resulted in an impaired response to KCO/KCI. Clinical studies showed that KCOs dilated cerebral arteries and increased CBF, however, glibenclamide failed to attenuate these vascular changes. Endothelial K
channels played a major role in CBF regulation. More studies investigating the role of K
channels in CBF-related structures are needed to further elucidate their actual role in cerebral hemodynamics in humans.
Prospero: CRD42023339278 (preclinical data) and CRD42022339152 (clinical data). |
---|---|
ISSN: | 1664-2295 1664-2295 |